glp 1 macular degeneration Diabetes Weight Loss Drugs May Double Risk of GLP-1s May Protect Against AMD

Description

Some GLP-1 medications have demonstrated cardiovascular benefits in clinical trials (such as LEADER for liraglutide, SUSTAIN-6 for semaglutide, and REWIND for dulaglutide), and discontinuation may result in loss of these protective effects

James Wantuck, chief medical officer of Accolade and PlushCare

O, en este caso con la enfermedad heptica metablica, podramos usar solo una dosis ms pequea del medicamento y no tener tantos eventos adversos, y no le costara al paciente tanto dinero porque no est tomando tanta cantidad del frmaco

While GLP-1 drugs have existed since the early 2000s, semaglutide revealed their potential beyond diabetes, particularly in obesity, where past treatments were often found inadequate